Background illustration for clinical trials search

Paid Clinical Trials Surprise

Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

for
Gout
Location: Phoenix AZ, Tucson AZ, Las Vegas NV, Tustin CA,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07535034

Phase 2, Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

for
Psoriatic Arthritis
Location: Phoenix AZ, Chandler AZ, La Mesa CA, Fountain Valley CA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06671483

Phase 3, Recruiting
New

Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1

for
Complex Regional Pain Syndrome Type I
Location: Phoenix AZ
Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07857733

Phase 3, Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

for
Complex Regional Pain Syndrome Type I
Location: Phoenix AZ, Tucson AZ, La Jolla CA, Tustin CA,
Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07210515

Phase 3, Recruiting

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

for
Focal Onset Seizure, Primary Generalized Epilepsy
Location: Phoenix AZ, Round Rock TX, Seabrook TX, Chesterfield MO,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 18 - 70+

Code: NCT06908356

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Phoenix AZ, La Jolla CA, Upland CA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase 3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Phoenix AZ, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase 1, Phase 2, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Phoenix AZ, Santa Rosa CA, Tyler TX, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase 1, Phase 2, Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Phoenix AZ, Newport Beach CA, El Paso TX, Champaign IL,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07652658

Phase 2, Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Phoenix AZ, Salt Lake City UT, Portland OR,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT07165132

Phase 1, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Phoenix AZ, La Jolla CA, Irvine CA, Orange CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Phoenix AZ, Tucson AZ, Orange CA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Phoenix AZ, Los Alamitos CA, Tacoma WA, Springfield MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Phoenix AZ, San Diego CA, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Amarillo TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Phoenix AZ, Los Angeles CA, Stanford CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase 3, Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for
Hepatocellular Carcinoma (HCC)
Location: Phoenix AZ, Orange CA, Houston TX, Omaha NE, Seattle WA,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase 1, Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Phoenix AZ, San Diego CA, Redlands CA, Loma Linda CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

for
Respiratory Syncytial Virus (RSV)
Location: Phoenix AZ, San Antonio TX, Omaha NE, Metairie LA,
Sponsor: Meissa Vaccines, Inc.

Sex: All

Age: 0 - 3

Code: NCT04909021

Phase 1, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Phoenix AZ, Chandler AZ, San Diego CA, Orange CA,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase 3, Recruiting